Vertex Pharmaceuticals Inc
Market cap $130.9B
$508.54
VRTX
$508.54
-1.51% today
Buy with €1M virtual cash · No real money
Vertex Pharmaceuticals Inc (VRTX) is a publicly traded company listed on the XNAS. As of September 18, 2026, Invest's signal rates VRTX a Buy, with the stock up 31% over the past year. You can practice trading VRTX risk-free with €1,000,000 in virtual cash.
Key stats
As of September 18, 2026
Market Cap
$130.9B
Volume
418K
52-wk High
$560.25
52-wk Low
$374.17
Day High
$518.10
Day Low
$508.23
P/E (TTM)
29.62
Revenue (TTM)
$12.6B
EPS (TTM)
$17.17
Performance
1M
-7.9%
6M
+11.0%
1Y
+31.4%
Invest signal · VRTX
BuyAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
VRTX overview
AI overviewRevenue & EPS — last 8 quarters
QoQ rev +11.6%Revenue
$3BEPS (diluted)
$4.31 per shareLatest VRTX news
Aerska Appoints Laura Sepp-Lorenzino to Scientific Advisory Board
GlobeNewswire Inc. · 1d ago
SION to Cut Workforce by Nearly Half After CF Study Failure, Stock Down
Zacks Investment Research · 1d ago
My Top 5 Favorite Stocks for an Uncertain Market
The Motley Fool · 2d ago
Should You Invest in the VanEck Biotech ETF (BBH)?
Zacks Investment Research · 2d ago
AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool · 3d ago
About Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults.
Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Employees
6,400
30-Day Win Rate · VRTX
13 days
11 days
Last 24 sessions
How to practice trading VRTX
- 1
Use the VRTX buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top VRTX traders on Invest
Full leaderboardFrequently asked questions
Is VRTX a good stock to buy right now?
As of September 18, 2026, Invest's signal rates VRTX a Buy, based on its price trend, valuation, and fundamentals (P/E around 29.6), with the stock up 31% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading VRTX risk-free first.
What is Vertex Pharmaceuticals Inc's (VRTX) market cap?
Vertex Pharmaceuticals Inc has a market capitalization of approximately $130.9B, on trailing-twelve-month revenue of about $12.6B.
How has VRTX stock performed?
VRTX is up 31% over the past year and up 11% over six months. Its 52-week range runs roughly from $374.17 to $560.25. Past performance doesn't predict future results.
How can I practice trading VRTX for free?
On Invest you get €1,000,000 in virtual cash and can buy VRTX at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare VRTX with peers